CGIX Cancer Genetics, Inc. Stock Quote

CGIX [NASD]

Index	-	P/E	-	EPS (ttm)	-1.85	Insider Own	7.49%	Shs Outstand	10.56M	Perf Week	19.72%
Market Cap	61.31M	Forward P/E	-	EPS next Y	-	Insider Trans	0.00%	Shs Float	3.51M	Perf Month	47.25%
Income	-4.10M	PEG	-	EPS next Q	-	Inst Own	5.40%	Short Float	32.74%	Perf Quarter	141.39%
Sales	6.30M	P/S	9.73	EPS this Y	22.70%	Inst Trans	99.24%	Short Ratio	0.49	Perf Half Y	-2.64%
Book/sh	2.06	P/B	2.86	EPS next Y	-	ROA	-35.70%	Target Price	-	Perf Year	40.57%
Cash/sh	0.11	P/C	55.74	EPS next 5Y	40.00%	ROE	-76.50%	52W Range	1.92 - 17.50	Perf YTD	112.64%
Dividend	-	P/FCF	-	EPS past 5Y	41.70%	ROI	-59.00%	52W High	-66.34%	Beta	2.74
Dividend %	-	Quick Ratio	0.60	Sales past 5Y	-6.50%	Gross Margin	45.70%	52W Low	206.77%	ATR	1.10
Employees	110	Current Ratio	0.60	Sales Q/Q	-23.80%	Oper. Margin	-69.70%	RSI (14)	53.44	Volatility	18.07% 19.11%
Optionable	No	Debt/Eq	0.04	EPS Q/Q	75.50%	Profit Margin	-71.50%	Rel Volume	0.21	Prev Close	6.23
Shortable	Yes	LT Debt/Eq	0.02	Earnings	-	Payout	-	Avg Volume	2.33M	Price	5.89
Recom	3.00	SMA20	4.07%	SMA50	38.54%	SMA200	63.95%	Volume	478,942	Change	-5.46%

Dec-07-17

Initiated

Maxim Group

Buy

Jun-27-17

Initiated

Dawson James

Buy

Jun-26-17

Initiated

The Benchmark Company

Speculative Buy

Sep-26-16

Initiated

Rodman & Renshaw

Buy

Feb-16-21 04:45PM	Cancer Genetics Announces Closing of $17.5 Million Common Stock Offering Priced At-the-Market under Nasdaq Rules GlobeNewswire +6.85%
Feb-11-21 07:26AM	The Daily Biotech Pulse: DermTech Soars On Contract, Fluidigm Plunges On Earnings, Decision Day For Regeneron, Bioventus Debuts Benzinga -18.14%
Feb-10-21 11:00PM	Cancer Genetics Announces $17.5 Million Common Stock Offering Priced At-the-Market under Nasdaq Rules GlobeNewswire +49.05%
Feb-06-21 11:52AM	INVESTIGATION ALERT: Halper Sadeh LLP Investigates NK, ALXN, CATM, CGIX, MTSC; Shareholders Are Encouraged to Contact the Firm PR Newswire
Feb-05-21 09:00PM	STOCKHOLDER ALERT: Monteverde & Associates Continues to Investigate the Following Merger ACCESSWIRE
Feb-04-21 03:45AM	INVESTIGATION ALERT: Halper Sadeh LLP Investigates PRGX, RP, NK, CGIX; Shareholders Are Encouraged to Contact the Firm ACCESSWIRE
Feb-03-21 06:00PM	SHAREHOLDER ALERT: Monteverde & Associates Continues to Investigate the Following Merger ACCESSWIRE +16.85%
Feb-01-21 05:16PM	Cancer Genetics Announces Closing of $10.0 Million Private Placement Priced At-the-Market GlobeNewswire -6.50%
Jan-30-21 07:06PM	Halper Sadeh LLP Continues to Investigate the Following Mergers; Shareholders Are Encouraged to Contact the Firm - CPAH, UROV, ANH, CGIX, CBLI, NEOS PR Newswire
Jan-28-21 06:15PM	SHAREHOLDER ALERT: Monteverde & Associates Continues to Investigate the Following Merger ACCESSWIRE +37.14%
04:02PM	Cancer Genetics Announces $10.0 Million Private Placement Priced At-the-Market GlobeNewswire
Jan-16-21 02:54PM	ALERT: Halper Sadeh LLP Reminds Investors of Its Ongoing Merger Investigations; Shareholders are Encouraged to Contact the Firm CBMG, CGIX, UROV GlobeNewswire
Jan-14-21 05:27PM	SHAREHOLDER ALERT: WeissLaw LLP Reminds CGIX, NPA, THBR and GIX Shareholders About Its Ongoing Investigations PR Newswire
Jan-09-21 10:29AM	Halper Sadeh LLP Investigates the Following Mergers; Shareholders are Encouraged to Contact the Firm - MTSC, PRVL, RLH, CGIX PR Newswire
Jan-07-21 04:06PM	SHAREHOLDER ALERT: WeissLaw LLP Reminds FIII, JWS, BRPA, and CGIX Shareholders About Its Ongoing Investigations PR Newswire +6.57%
04:05PM	Cancer Genetics to Present at the 2021 BioConnect Virtual Conference Hosted by H.C. Wainwright GlobeNewswire
Dec-19-20 04:17PM	SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates the Following Companies - STND, EIDX, WTRE, ARA, CGIX PR Newswire
Dec-18-20 10:28PM	WeissLaw LLP Reminds EIGI, GV, CGIX and ROCH Shareholders About Its Ongoing Investigations PR Newswire
Dec-08-20 12:12PM	INVESTIGATION ALERT: Halper Sadeh LLP Reminds Shareholders About Its Ongoing Merger Investigations; Investors are Encouraged to Contact the Firm - ANH, GV, ALSK, CLCT, CGIX PR Newswire +14.79%
Dec-07-20 04:54PM	WeissLaw LLP Reminds CGIX, ALSK, EIGI, and HDS Shareholders About Its Ongoing Investigations PR Newswire
Dec-01-20 07:14PM	Halper Sadeh LLP Reminds Shareholders About Its Ongoing Merger Investigations; Investors are Encouraged to Contact the Firm MVC, PTI, CGIX, STND GlobeNewswire
Nov-30-20 08:50PM	WeissLaw LLP Reminds CGIX, ALSK, EIGI, and HDS Shareholders About Its Ongoing Investigations PR Newswire +6.15%
Nov-18-20 08:00AM	Halper Sadeh LLP Announces it is Investigating the Following Mergers; Shareholders are Encouraged to Contact the Firm PNM, STND, CBMG, CGIX GlobeNewswire
Nov-17-20 12:10PM	Moore Kuehn Encourages CGIX, AKER, TGC and DNKN Investors to Contact Law Firm PR Newswire
Nov-13-20 10:37PM	SHAREHOLDER ALERT: Halper Sadeh LLP Reminds Shareholders About Its Investigations; Investors are Encouraged to Contact the Firm CBMG, MVC, PTI, CGIX GlobeNewswire
Nov-12-20 05:31PM	SHAREHOLDER ALERT: WeissLaw LLP Investigates Cancer Genetics, Inc. PR Newswire
04:25PM	Cancer Genetics Reports Third Quarter 2020 Financial Results GlobeNewswire
12:25PM	Moore Kuehn Encourages CGIX, CXO, CBMG, and RESI Investors to Contact Law Firm GlobeNewswire
Nov-02-20 04:00PM	Cancer Genetics, Inc. Announces Closing of Public Offering and Full Exercise of the Underwriters Option to Purchase Additional Shares GlobeNewswire
Oct-28-20 09:55PM	Cancer Genetics, Inc. Increases Previously Announced Bought Deal to $3.0 Million GlobeNewswire -7.10%
05:54PM	Cancer Genetics, Inc. Announces $2.0 Million Bought Deal Offering GlobeNewswire
Oct-20-20 12:30PM	SHAREHOLDER ALERT: Halper Sadeh LLP is Investigating the Following Companies; Investors are Encouraged to Contact the Firm MVC, CGIX, MOBL, STND ACCESSWIRE
Oct-19-20 03:24PM	SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of EIDX, ARA, MVC, and CGIX Mergers GlobeNewswire -7.62%
Oct-14-20 07:00PM	SHAREHOLDER ALERT: Halper Sadeh LLP is Investigating the Following Companies; Investors are Encouraged to Contact the Firm CBMG, CGIX, VRTU, MOBL ACCESSWIRE
01:14PM	SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of EIDX, VRTU, CBMG, and CGIX Mergers GlobeNewswire
Oct-13-20 08:20PM	ALERT: Halper Sadeh LLP is Investigating the Following Companies; Investors are Encouraged to Contact the Firm CBMG, CGIX, BLDR, VRTU ACCESSWIRE
Oct-09-20 08:01AM	Lifshitz Law Firm, P.C. Announces Investigation of American Renal Associates Holdings, Inc. (NYSE: ARA), BMC Stock Holdings, Inc., Builders FirstSource, Inc., Cancer Genetics, Inc., Cellular Biomedicine Group, Inc., Eidos Therapeutics, Inc., Montage Resources Corporation, MyoKardia, Inc. and Yintech Investment Holdings Limited PR Newswire
Oct-05-20 05:55PM	ALERT: Halper Sadeh LLP is Investigating the Following Companies; Investors are Encouraged to Contact the Firm - CGIX, STND, BLDR, DCOM ACCESSWIRE
Oct-02-20 08:01PM	Lifshitz Law Firm, P.C. Announces Investigation of BMC Stock Holdings, Inc. (NASDAQ:BMCH), Cancer Genetics, Inc. (NASDAQ: CGIX), Cellular Biomedicine Group, Inc. (NASDAQ: CBMG), and Varian Medical Systems, Inc. (NYSE: VAR) GlobeNewswire
Sep-26-20 03:01AM	IMPORTANT SHAREHOLDER ALERT: Halper Sadeh LLP Reminds Shareholders About Its Ongoing Investigations; Investors are Encouraged to Contact the Firm - CGIX, YIN, OTEL, BMCH PR Newswire
Sep-25-20 04:55PM	Lifshitz Law Firm, P.C. Announces Investigation of Akcea Therapeutics, Inc. (NASDAQ: AKCA), BMC Stock Holdings, Inc. (NASDAQ: BMCH), Builders FirstSource, Inc. (NASDAQ: BLDR), Cancer Genetics, Inc. (NASDAQ: CGIX), Cellular Biomedicine Group, Inc. (NASDAQ: CBMG), Otelco Inc. (NASDAQ: OTEL), Rosetta Stone Inc. (NYSE: RST), Varian Medical Systems, Inc. (NYSE: VAR), and Yintech Investment Holdings Limited (NASDAQ: YIN) PR Newswire
Sep-24-20 03:55PM	ALERT: Halper Sadeh LLP Reminds Investors About Its Ongoing Investigations; Shareholders are Encouraged to Contact the Firm BDGE, CBMG, CGIX, BMCH ACCESSWIRE
10:48AM	Moore Kuehn Encourages BDGE, CBMG, CGIX, and BMCH Investors to Contact Law Firm GlobeNewswire
Sep-23-20 11:45PM	IMPORTANT SHAREHOLDER ALERT: Halper Sadeh LLP Is Investigating the Following Companies; Shareholders are Encouraged to Contact the Firm CGIX, BYFC, BMCH, AKCA ACCESSWIRE -6.55%
03:00PM	SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of AIMT, BMCH, BYFC, and CGIX Mergers GlobeNewswire
Sep-17-20 02:50PM	ALERT: Halper Sadeh LLP Is Investigating the Following Mergers; Shareholders are Encouraged to Contact the Firm IMMU, PTI, CGIX, JCAP ACCESSWIRE +8.73%
Sep-16-20 01:24PM	Lifshitz Law Firm, P.C. Announces Investigation of Aimmune Therapeutics, Inc., (NASDAQ:AIMT), Akcea Therapeutics, Inc., (NASDAQ:AKCA), BMC Stock Holdings, Inc., (NASDAQ:BMCH), and Cancer Genetics, Inc., (NASDAQ:CGIX) GlobeNewswire
Sep-12-20 11:00AM	ALERT: Halper Sadeh LLP Continues to Investigate the Following Mergers; Shareholders are Encouraged to Contact the Firm GLIBA, CGIX, JCAP ACCESSWIRE
Sep-10-20 08:50PM	Lifshitz Law Firm, P.C. Announces Investigation of Aimmune Therapeutics, Inc., Akcea Therapeutics, Inc., BMC Stock Holdings, Inc., Builders FirstSource, Inc., Broadway Financial Corporation, Cancer Genetics, Inc., Proteostasis Therapeutics, Inc., Rosetta Stone Inc., and Yintech Investment Holdings Limited PR Newswire
08:00AM	Cancer Genetics Announces Participation at the 22nd Annual Rodman & Renshaw Global Investment Conference GlobeNewswire
Sep-03-20 08:00AM	Cancer Genetics and StemoniX Announce Joint Proof-of-Concept Program GlobeNewswire -6.43%
01:10AM	ALERT: Halper Sadeh LLP Is Investigating the Following Mergers; Shareholders are Encouraged to Contact the Firm PTI, CGIX, BYFC, BLDR ACCESSWIRE
Sep-02-20 08:00PM	SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of BMCH, BYFC, CGIX, and PTI Mergers GlobeNewswire
Sep-01-20 10:30PM	INVESTIGATION ALERT: Halper Sadeh LLP Continues to Investigate the Following Mergers; Shareholders are Encouraged to Contact the Firm CGIX, BMCH, GLIBA, DCOM ACCESSWIRE +7.08%
07:17PM	Lifshitz Law Firm, P.C. Announces Investigation of Cancer Genetics, Inc., Momenta Pharmaceuticals, Inc., Principia Biopharma Inc., and Yintech Investment Holdings Limited GlobeNewswire
Aug-31-20 11:36AM	INVESTOR ALERT: Monteverde & Associates PC Announces an Investigation of Cancer Genetics, Inc. - CGIX PR Newswire -11.24%
Aug-27-20 04:35PM	INVESTIGATION ALERT: Halper Sadeh LLP Continues to Investigate the Following Mergers; Shareholders are Encouraged to Contact the Firm PTI, CGIX, YIN, NETE ACCESSWIRE
12:45PM	MERGER ALERT CGIX, PRNB, and MNTA: Levi & Korsinsky, LLP Reminds Investors of Investigations Concerning the Mergers of these Companies ACCESSWIRE
10:59AM	Moore Kuehn Encourages MXIM, CGIX, PTI, and DCOM Investors to Contact Law Firm GlobeNewswire
Aug-26-20 06:39PM	Lifshitz Law Firm, P.C. Announces Investigation of Cancer Genetics, Inc., Jernigan Capital, Inc., Momenta Pharmaceuticals, Inc., NTN Buzztime, Inc., Principia Biopharma Inc., Spring Bank Pharmaceuticals, Inc., Varian Medical Systems, Inc., and Yintech Investment Holdings Limited PR Newswire -9.08%
06:09PM	CANCER GENETICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Cancer Genetics, Inc. - CGIX Business Wire
Aug-25-20 06:10PM	ALERT: Halper Sadeh LLP Continues to Investigate the Following Mergers; Shareholders are Encouraged to Contact the Firm INWK, CGIX, NTN, YIN ACCESSWIRE
03:00PM	CANCER GENETICS, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation of Merger Newsfile
10:21AM	Company News for Aug 25, 2020 Zacks
08:38AM	The Daily Biotech Pulse: Altimmune Reports Positive Preclinical Data For Intranasal COVID-19 Vaccine, AbbVie Licenses Morphic's Drug, Viveve Clinical Readout Benzinga
06:20AM	Cancer Genetics Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Merger of Cancer Genetics, Inc. is Fair to Shareholders; Investors are Encouraged to Contact the Firm PR Newswire
Aug-24-20 05:58PM	SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Regarding Whether the Merger of Cancer Genetics, Inc. and StemoniX, Inc. is Fair to CGIX Shareholders Newsfile +115.52%
03:41PM	Why Cancer Genetics Is Trading Higher Today Benzinga
08:00AM	Cancer Genetics and StemoniX Sign Definitive Agreement to Merge GlobeNewswire
Aug-14-20 07:30AM	Cancer Genetics Reports Second Quarter 2020 Financial Results GlobeNewswire
Jun-24-20 05:30PM	Cancer Genetics Reports First Quarter 2020 Financial Results and Provides Strategic Business Updates GlobeNewswire -5.65%
Jun-01-20 08:00AM	Cancer Genetics Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Strategic Business Updates GlobeNewswire
May-12-20 06:37AM	Those Who Purchased Cancer Genetics (NASDAQ:CGIX) Shares Five Years Ago Have A 99% Loss To Show For It Simply Wall St.
Feb-20-20 09:00AM	Cancer Genetics Issues Letter to Shareholders GlobeNewswire +28.91%
Nov-20-19 08:00AM	Cancer Genetics Reports Third Quarter 2019 Financial Results and Provides Strategic Business Update GlobeNewswire +131.25%
Nov-14-19 05:29AM	Introducing Cancer Genetics (NASDAQ:CGIX), The Stock That Collapsed 98% Simply Wall St. -5.82%
Oct-24-19 04:15PM	Cancer Genetics, Inc. Announces Strategic Transactions GlobeNewswire -19.06%
08:30AM	Cancer Genetics Announces 1-for-30 Reverse Stock Split GlobeNewswire
Oct-17-19 06:55AM	Interpace Announces Closing of $13 Million Second Tranche Acquisition Financing from Ampersand Capital Partners GlobeNewswire
Aug-20-19 08:00AM	Cancer Genetics Reports Second Quarter 2019 Financial Results and Provides Strategic Business Update GlobeNewswire
Jul-16-19 12:44PM	A Look At Benzinga Pro's Most-Searched Tickers For July 16, 2019 Benzinga +18.52%
08:44AM	Cancer Genetics Sharply Higher After Interpace Buys Biopharma Unit Benzinga
Jul-15-19 04:22PM	Cancer Genetics, Inc. Announces Strategic Transactions GlobeNewswire
04:10PM	Interpace Diagnostics Acquires Cancer Genetics Biopharma Services Business Supported by Investment from Ampersand Capital Partners GlobeNewswire
Jun-25-19 07:24AM	Triangle pharma brings in new CFO looking for capital American City Business Journals
Jun-24-19 07:00AM	Innovate Biopharmaceuticals Expands Its Management team with the Addition of Ed Sitar as Its Chief Financial Officer GlobeNewswire
Jun-05-19 02:00AM	LabCorp (LH) Closes Envigo Swap Deal, Expands in CRO Space Zacks
May-20-19 05:06PM	Cancer Genetics: 1Q Earnings Snapshot Associated Press
05:00PM	Cancer Genetics Reports First Quarter 2019 Financial Results and Provides Strategic Business Update GlobeNewswire
Apr-16-19 07:22AM	Cancer Genetics: 4Q Earnings Snapshot Associated Press
07:00AM	Cancer Genetics Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Strategic Business Updates GlobeNewswire
Mar-26-19 08:06AM	Investors Who Bought Cancer Genetics (NASDAQ:CGIX) Shares Five Years Ago Are Now Down 98% Simply Wall St.
Feb-14-19 07:04AM	Could The Cancer Genetics, Inc. (NASDAQ:CGIX) Ownership Structure Tell Us Something Useful? Simply Wall St.
Jan-31-19 04:01PM	Cancer Genetics, Inc. Announces Closing of Public Offering of Common Stock GlobeNewswire
Jan-29-19 07:25AM	The Daily Biotech Pulse: Big Pharma Earnings, Kiniksa Offering, FDA Decision Day For Aquestive Benzinga -15.75%
Jan-28-19 10:33PM	Cancer Genetics, Inc. Announces Pricing of $3.5 Million Public Offering of Common Stock GlobeNewswire
04:00PM	Cancer Genetics, Inc. Announces Proposed Public Offering of Common Stock GlobeNewswire
Jan-21-19 09:21AM	Insider Buys Of The Week: Cancer Genetics, Dish Network, Valvoline Benzinga
Jan-16-19 08:45AM	Cancer Genetics Issues Letter to Shareholders GlobeNewswire +6.56%
Jan-14-19 05:29PM	Cancer Genetics, Inc. Announces Closing of Public Offering of Common Stock GlobeNewswire -6.58%

Cancer Genetics, Inc., through its subsidiary, vivoPharm, Pty Ltd., provides contract research services primarily focusing on studies to guide drug discovery and development programs in the oncology and immuno-oncology fields. The company's clinical offerings include a portfolio of proprietary tests, such as comparative genomic hybridization microarrays and next generation sequencing panels, gene expression tests, and DNA fluorescent in situ hybridization probes targeting hematological, and human papillomavirus-associated cancers, which include cervical, anal, head, and neck cancers. It serves the biotechnology and pharmaceutical customers in the United States, Europe, and Australia. Cancer Genetics, Inc. was founded in 1999 and is headquartered in Rutherford, New Jersey.

open in yahoo | open in reuters | open in google

Upgrade your FINVIZ experience